JIISX | VTSMX | JIISX / VTSMX | |
Total Expense Ratio | 0.39 | 0.14 | 279% |
Annual Report Gross Expense Ratio | 0.74 | 0.14 | 529% |
Fund Existence | 22 years | 33 years | - |
Gain YTD | 7.885 | 8.287 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 281M | 1.91T | 0% |
Annual Yield % from dividends | 0.72 | 1.12 | 64% |
Returns for 1 year | 17.17 | 17.75 | 97% |
Returns for 3 years | 66.02 | 60.60 | 109% |
Returns for 5 years | 93.68 | 93.51 | 100% |
Returns for 10 years | 160.33 | 200.97 | 80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LDVIX | 30.25 | 0.17 | +0.57% |
AXS FTSE Vntr Cptl RetTrckr I | |||
AFDGX | 55.81 | 0.29 | +0.52% |
American Century Large Cap Equity R5 | |||
DYGAX | 14.82 | 0.04 | +0.27% |
Meeder Dynamic Allocation Adviser | |||
ETNHX | 34.00 | -0.01 | -0.03% |
Eventide Healthcare & Life Sciences N | |||
RERFX | 61.53 | -0.33 | -0.53% |
American Funds EUPAC R5 |